PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. (Q40203803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

main subject

hepatocellular carcinoma

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Wolfgang Mikulits

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Fischer AN

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Fuchs E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Huber H

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Beug H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

20 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

number of pages

11

1 reference

inferred from page(s)

published in

Oncogene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

3395-3405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210121

22 December 2019

exact match

0 references

cites work

Anti-adipogenic effect of PDGF is reversed by PKC inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Chronic liver injury, TGF-beta, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Genetics of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Integration of Ras subeffector signaling in TGF-beta mediated late stage hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Tumour-cell invasion and migration: diversity and escape mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Repression of beta-catenin function in malignant cells by nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Immortalized p19ARF null hepatocytes restore liver injury and generate hepatic progenitors after transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

The plasticity of p19 ARF null hepatic stellate cells and the dynamics of activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

A role for Wnt signalling in self-renewal of haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

The two faces of transforming growth factor beta in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Biology of transforming growth factor beta in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

7 January 2021

Tumor Antigen Pulsed Dendritic Cells Enhance the Cytolytic Activity of Tumor Infiltrating Lymphocytes in Human Hepatocellular Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

7 January 2021

Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

7 January 2021

A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

7 January 2021

Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

7 January 2021

Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210121

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17130832%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 December 2019

0 references

1 reference